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BACKGROUND: Highly efficient retrovirus-mediated gene transfer into
hepatocytes in vivo triggers an immune response directed against transduced
hepatocytes. This effect may be due either to spreading of retroviral vectors in the
blood stream with subsequent infection of antigen presenting cells (APCs) or to
cross-presentation of the transgene product present as a contaminant in the viral
stock. In order to decrease immune response, we evaluated the effect of
asanguineous perfusion of the liver as well as purification of the viral stock on
long-term transduction of hepatocytes using the nls-lacZ marker gene.
METHODS: Animals were divided in four groups. In group 1, the viral
supernatant was perfused in the regenerating liver after complete vascular
exclusion of the organ. In group 2, using the same strategy, animals received
retroviral supernatant that was passed through a beta-galactosidase affinity
column to reduce beta-galactosidase contamination. In two control groups
(respectively groups 3 and 4) the corresponding viral supernatants were delivered
via peripheral injection.
RESULTS: In group 1, 23.1% of animals had no immune response 2 months after
gene delivery vs. 33.4% in group 2, 4.3% in control group 3, and 0% in control
group 4. Statistical analysis of the results demonstrated that only the difference
between groups 2 and 3 was statistically significant. This indicated that both
asanguineous perfusion together with passage through an affinity column were
required to decrease significantly immune response.
CONCLUSIONS: Our present results suggest that both supernatant
contamination and viral spreading contribute to immune response after retrovirus-
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